By Christopher Cannon, Manager, Health Care Access, NASTAD
Prior to the approval of Truvada as PrEP, health departments feared there would be a rush of affluent gay men demanding access to Pre-Exposure Prophylaxis (PrEP)-the use of antiretroviral medication to prevent the infection of HIV-to abandon condom use altogether. In so doing, they would create greater health disparities among vulnerable populations like young gay and bisexual men, Black and Latino gay and bisexual men, and transgender women who are often disenfranchised. However interest in PrEP outside of clinical trials across the country has been very limited. Gilead, manufacturer of Truvada, reports only 2,319 prescriptions filled for Truvada as PrEP from January 1, 2012 (prior to FDA approval in July 2012) to September 30, 2013 in the United States, which currently has an estimated 50,000 HIV infections each year. Continue reading
June 16, 2014 – This month, as part of on-going efforts to explore and address community- and institution-level stigma impacting Black and Latino gay men and MSM within public health practice, the National Alliance of State and Territorial AIDS Directors (NASTAD) and the National Coalition of STD Directors (NCSD) are re-launching an updated survey assessment to continue efforts to monitor stigma in public health practice. Through support from the MAC AIDS Fund, NASTAD and NCSD conducted a three-year study of stigma and its impact on public health practice for Black and Latino gay men/MSM. This work included a national survey of more than 1,300 respondents; the convening of a Blue Ribbon Panel of stakeholders and medical providers; the publication of “Optimal Care Checklists” for providers and for Black and Latino gay male patients; and the convening of a National Stigma Summit on Black and Latino Gay Men’s Health. Continue reading
June 11, 2014 – The National Alliance of State and Territorial AIDS Directors (NASTAD) and the National Coalition of STD Directors (NCSD) are launching “Addressing Stigma: A Blueprint for HIV/STD Prevention and Care Outcomes for Black and Latino Gay Men.” The blueprint contains 17 recommendations for reducing public health stigma that prevents Black and Latino gay men and other men who have sex with men (MSM) from receiving optimal health care. Health departments will receive four courtesy copies via mail to distribute across programs (i.e., HIV prevention and care, STD programs).
The content of this post originally appeared in The Roll Out, a Newsletter of CDC-Ethiopia and Partners, in December 2013.
Mainstreaming HIV/AIDS in Higher Education Institutions
The Roll Out, a Newsletter of CDC-Ethiopia and Partners
Since the issue of HIV/AIDS was brought forward as one of the major health challenges of Ethiopia, lots of public and private organizations, including higher education institutions (HEI) in the country have been responding to it in many different ways. The interventions in most of these HEIs are characterized by sidelined, on the fringe activities with lack of coordination and sustainability. As HIV/AIDS continues to be a threat and constitutes a big problem among colleges and universities in Ethiopia, there is a need for comprehensive, prompt and sustainable programming. Mainstreaming brings HIV/AIDS to the center of these organizations’ agendas along with the core activities, integrating it into the main objectives of the institutions.
By Dawn Fukuda, Director, Office of HIV/AIDS, Massachusetts Department of Public Health and NASTAD Chair (Outgoing)
Director, Office of HIV/AIDS, Massachusetts Department of Public Health and NASTAD Chair
As I began my tenure as chair of the National Alliance of State and Territorial AIDS Directors (NASTAD) in May 2013, I was full of energy and optimism. January 1st of 2014 was close at hand, and represented a massive new opportunity to invigorate our response to the HIV and viral hepatitis epidemics through the implementation of the Affordable Care Act (ACA).
I was confident based on our experience with state health care reform in my home state of Massachusetts that increased access to medical care through broader insurance coverage would translate into health promotion and disease prevention outcomes that would advance our progress along the HIV Care Continuum. I remain steadfast in my belief that integrating an HIV and viral hepatitis response into primary medical care and reimbursable health services is the way to sustain our efforts into the future; yet the mechanics of the ACA roll out over the past year also provide a striking reminder of the essential and non-transferrable role of public health.